Total trials
121
Active
20
Phase 3
4
Total enrollment
139,907
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Spinal Anesthesia with Ropivacaine 15 mg | — | — | — | — | — | 1 | |
| Spinal Anesthesia with Bupivacaine 11 mg | — | — | — | — | — | 1 |
Next readouts
- 2027-12
Top conditions
- Atrial Fibrillation10
- Healthy5
- Coronary Artery Disease4
- Physical Activity4
- Dental Caries3
- Stroke3
- Leadership3
- Cardiovascular Diseases3
Frequently asked questions about University of Turku
- How many clinical trials does University of Turku have on ClinicalTrials.gov?
- University of Turku is listed as the lead sponsor on 121 clinical trials in ClinicalTrials.gov, 20 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Turku's trials are in Phase 3?
- 4 of University of Turku's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does University of Turku focus on?
- University of Turku's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, Healthy, Coronary Artery Disease, Physical Activity, Dental Caries.
- When are University of Turku's next clinical trial readouts?
- University of Turku has 1 upcoming primary-completion readout tracked here; the soonest is “Post-Operative Spinal Block Duration and Pain Relief After Hip Replacement Surgery: Comparing Single-Shot Spinal Ropivacaine and Bupivacaine”, expected around 2027-12.